The latest report published by IMARC Group, titled “Influenza Vaccine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the influenza vaccine market trends. The report also includes competitor and regional analysis, and contemporary advancements in the market.
The global influenza vaccine market size reached US$ 5.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.1 Billion by 2027, exhibiting a CAGR of 7.9% during 2022-2027.
Industry Overview and Application:
Influenza refers to a contagious viral infection that is caused due to flu in the respiratory system. It is characterized by fever, cough, muscle and joint pain, headache, and severe weakness. It can further spread from one person to another through respiratory droplets or physical contact. Currently, influenza can be treated by quadrivalent, inactivated, live attenuated and trivalent vaccinations that are suitable for various demographics, including new-borns, infants, and geriatrics. These medications reduce the risk of flu-associated hospitalization; therefore, they are administered via nasal spray or injections to protect patients from the influenza virus.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/influenza-vaccine-market/requestsample
Influenza Vaccine Market Trends:
The escalating prevalence of influenza and the growing geriatric population who are suspectable to various chronic diseases, including diabetes, cancer, and human immunodeficiency virus (HIV), are primarily driving the influenza vaccine market growth. Additionally, the numerous initiatives being undertaken by governments to monitor the production, availability, distribution, effectiveness, and side effects of the influenza vaccine after administration are favoring the market growth. Moreover, licensing of several seasonal influenza medications and the ongoing immunization programs to offer compulsory flu vaccinations are propelling the market growth. Furthermore, the rising awareness amongst the population regarding the risk of getting affected and the fueling focus on developing combination messenger ribonucleic acid (mRNA) vaccines to deal with COVID-19 and influenza are impelling the market growth. Besides this, increasing healthcare expenditure and continuous research and development (R&D) activities to launch therapeutically effective vaccines are supporting the market growth.
Influenza Vaccine Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the influenza vaccine market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
Key Market Segmentation:
The report has segmented the influenza vaccine market on the basis of vaccine type, technology, age group, route of administration and region.
Breakup by Vaccine Type:
Breakup by Technology:
Breakup by Age Group:
Breakup by Route of Administration:
Breakup by Region:
Explore Full Report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4206&flag=C
Key Highlights of the Report:
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Browse Related Reports:
Biodegradable Diapers Market: https://bit.ly/3qEArr2
US Healthcare Advertising Market: https://bit.ly/3fjrqkW
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Media ContactCompany Name: IMARC GroupContact Person: Elena AndersonEmail: Send EmailPhone: +1-631-791-1145Address:30 N Gould St Ste R City: SheridanState: WYCountry: United StatesWebsite: https://www.imarcgroup.com
